-
Limiting Surgery in Early-stage Breast CancerClinical trial presented at SABCS finds some patients may safely skip sentinel lymph node biopsy.
by Thomas Celona
-
New Hormone Therapy Extends Remission in Early-stage Hormone Receptor-positive Breast CancerMaintenance treatment with an oral selective estrogen receptor degrader reduced recurrence in early-stage hormone receptor-positive breast cancers.
by Marci A. Landsmann
-
Lifestyle Factors and Breast Cancer RiskSABCS educational session highlights how alcohol and obesity can raise the risk for breast cancer.
by Thomas Celona
-
From the Editor-in-Chief
Adjuvant Therapy: How Much Do Patients Really Need?Sensitive tests help guide treatment decisions.
by William G. Nelson, MD, PhD
-
Forward Look
The Lasting Benefits of ImmunotherapyThoracic oncologist Mark Awad discusses how immune responses can persist even after people with lung cancer stop receiving immunotherapy.
by Ashley P. Taylor
-
Forward Look
Getting Ahead of Cancer ProgressionSwitching medication based on early signs of treatment resistance resulted in longer cancer control in metastatic breast cancer.
by Jennifer Lawson
-
Forward Look
Targeted Therapy Combination Provides Deep RemissionsStudy shows a two-drug approach for chronic lymphocytic leukemia eliminates traces of cancer and offers lasting remissions.
by Darlene Dobkowski
-
Forward Look
Sponge-on-a-string Offers Screening AlternativeA quick, noninvasive sponge test accurately identified nearly 100% of low-risk Barrett esophagus patients without precancerous cells.
by Thomas Celona
-
Forward Look
A New First-line Option for Anal CancerPeople with advanced anal squamous cell carcinoma can now begin treatment with immunotherapy.
by Jeanette Beebe
-
Forward Look
Relieving Hot FlashesNonhormonal treatment may ease symptoms for women undergoing endocrine therapy for breast cancer.
by Lindsey Leake
The ‘Your Friends & Neighbors’ actress explains how her diagnosis challenged many of her assumptions about breast cancer.
by Darlene Dobkowski
Why I Participated in a Clinical TrialWhen doctors told Yvonne McLean Florence she was eligible to participate in a research trial testing an experimental drug, she joined. She wants more people to have the same opportunity.
by Yvonne McLean Florence
Targeted Therapy Improves Pancreatic Cancer SurvivalA recently approved drug that targets RAS proteins meaningfully improves outcomes for people with this difficult-to-treat cancer.
by Sandra Gordon
Bring On the WavesA surfer’s love for the ocean guides her through breast cancer treatment and beyond.
by Cameron Walker
-
AACR OMB Statement and Call to ActionThe AACR is deeply concerned that proposed OMB regulations would disrupt federal research grant giving, severely weakening a program that has supported American medical innovation for decades.
-
AACR Cancer Disparities Progress ReportThe AACR Cancer Disparities Progress Report 2026 highlights recent progress in reducing cancer disparities and emphasizes the continued need for transformative research.
Cancer Research at a Crossroads
